Top stablecoin firm Tether is joining forces with one of the winningest football clubs in the world. According to a new ...
Republican Vivek Ramaswamy is preparing to launch his 2026 bid for Ohio governor on Feb. 24 in his native Cincinnati, with ...
HER2, a HER2-targeted immunotherapy, with plans for FDA submission following promising Phase 2b data in osteosarcoma.
Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...
An Albuquerque-based firm is taking its first steps into a potentially game-changing partnership through an SBIR Phase I ...
Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...
The company is now expecting 2025 revenue to range from $1.5 billion to $2.5 billion, with a midpoint of $2.0 billion, while FactSet is expecting $2.4 billion. Most of that will come in the second ...
Corbus Pharmaceuticals has posted the first Western clinical data on its would-be rival to Pfizer’s Padcev. The overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback